sugemalimab
cstone pharmaceuticals
['lymphoma', 'sugemalimab']
#omniab partner cstone presents clinical results of #sugemalimab in patients with relapsed or refractory extranodal natural killer/t-cell #lymphoma via an oral abstract session at #asco22 
Offering best-in-class therapeutic antibody discovery technologies since 2012. Please read our Twitter Guidelines at: https://t.co/wfyZlfB5Gi